Esperion Therapeutics Inc. (NASDAQ: ESPR): Hunting Genuine Value In Market Debris
Two Seas Capital LP recently announced the acquisition of new stake in Esperion Therapeutics Inc. (NASDAQ:ESPR). The institutional investor has increased its shareholding in the Healthcare company by 160.79% to 7.67 million shares with purchase of 4.73 million shares. This fresh investment now brings its stake to 6.75% valued currently at $22.94 million. In addition, […]
Do Esperion Therapeutics Inc. (NASDAQ: ESPR) Fit In A Value Investing Philosophy?
Two Seas Capital LP recently announced the acquisition of new stake in Esperion Therapeutics Inc. (NASDAQ:ESPR). The institutional investor has increased its shareholding in the Healthcare company by 160.79% to 7.67 million shares with purchase of 4.73 million shares. This fresh investment now brings its stake to 6.75% valued currently at $10.2 million. In addition, […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) Stock In Prove Me State
Two Seas Capital LP has recently announced that it has increased stake in Esperion Therapeutics Inc. (NASDAQ:ESPR) by 160.79%. After grabbing 7.67 million shares, the institutional investor is now in possession of 4.73 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.75% having worth around $10.2 million. […]
Esperion Therapeutics Inc. (NASDAQ: ESPR): Stock That Needs Special Handling
Two Seas Capital LP recently announced the acquisition of new stake in Esperion Therapeutics Inc. (NASDAQ:ESPR). The institutional investor has increased its shareholding in the Healthcare company by 160.79% to 7.67 million shares with purchase of 4.73 million shares. This fresh investment now brings its stake to 6.75% valued currently at $10.2 million. In addition, […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) Hogging The Spotlight Today
Two Seas Capital LP recently announced the acquisition of new stake in Esperion Therapeutics Inc. (NASDAQ:ESPR). The institutional investor has increased its shareholding in the Healthcare company by 160.79% to 7.67 million shares with purchase of 4.73 million shares. This fresh investment now brings its stake to 6.75% valued currently at $10.2 million. In addition, […]
Following The Money: Institution’s Growing Stake In Esperion Therapeutics Inc. (NASDAQ: ESPR)
Two Seas Capital LP has recently announced that it has increased stake in Esperion Therapeutics Inc. (NASDAQ:ESPR) by 160.79%. After grabbing 7.67 million shares, the institutional investor is now in possession of 4.73 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.17% having worth around $6.36 million. […]
Are Analysts Expecting A Better 2020 For Esperion Therapeutics Inc. (ESPR)?
Two Seas Capital LP has recently announced that it has increased stake in Esperion Therapeutics Inc. (NASDAQ:ESPR) by 160.79%. After grabbing 7.67 million shares, the institutional investor is now in possession of 4.73 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.17% having worth around $6.36 million. […]
Esperion Therapeutics Inc. (NASDAQ: ESPR): Reassessing Prospects
Armistice Capital LLC has recently announced that it has increased stake in Esperion Therapeutics Inc. (NASDAQ:ESPR) by 149.86%. After grabbing 9.19 million shares, the institutional investor is now in possession of 5.51 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.59% having worth around $9.01 million. Moreover, […]
